[Drug treatment of obesity].
Yoshida
T
T
First Department of Internal Medicine, Kyoto Prefectural University of Medicine.
D018663:Adrenergic Agents / Q000627:therapeutic use*; D001337:Autonomic Agents / Q000627:therapeutic use; D005260:Female; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D008049:Lipase / Q000037:antagonists & inhibitors; D008297:Male; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
D018663:Adrenergic Agents; D001337:Autonomic Agents; D065089:Glycoside Hydrolase Inhibitors; D009292:Narcotic Antagonists; D017366:Serotonin Receptor Agonists; D008049:Lipase